The accuracy of your preclinical exposure data translation to humans can make or break the success of your Phase 1 clinical trial protocol.
Your team needs a first-in-human (FIH) prediction platform with robust functionality and models that can help you gain as much insight as possible. With the FIH Simulator, you can leverage our integrated PBPK technology to get the data you need to translate nonclinical data into an accurate starting dose for your FIH program, evaluate changes in your clinical plan and have early information on formulations design for your clinical program.
